<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876731</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A00381-42</org_study_id>
    <nct_id>NCT02876731</nct_id>
  </id_info>
  <brief_title>Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)</brief_title>
  <acronym>IMMETAOS</acronym>
  <official_title>Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Jean-Godinot</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Jean-Godinot</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, monocentric, comparative, non randomised

      Primary objective :

      - to compare the diagnostic accuracy of sodium fluoride PET-CT and MRI using the conventional
      block and diffusion sequence in the search for bone metastases

      Secondary objectives :

        -  compare accuracy of MRI diffusion and conventional MRI

        -  explore the evolution of the results of the different types of imaging over time or
           under treatment for patients with repeated examinations at 6 months
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, monocentric, comparative, non randomised.

      Organization of NaF PET-CT and MRI on the same day or within a 10 days period.

      At 6 months :

        -  repeat both exams systematically if one of the initial tests showed a suspicious or
           doubtful abnormality

        -  final diagnosis by a committee of practitioners using the whole patient's file

      Scheduled Project inclusion duration of 36 months (possible adaptation of duration in order
      to obtain the number of required patients)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of Bone metastasis according to a clinician and imaging practitionners group based on clinical and imaging evolution</measure>
    <time_frame>Up to 38 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Cancer</condition>
  <condition>Bone Metastasis</condition>
  <arm_group>
    <arm_group_label>single group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>PET-CT MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PET-CT</intervention_name>
    <description>NaF PET-CT</description>
    <arm_group_label>single group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>DWMRI</description>
    <arm_group_label>single group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman over 18 years

          -  Osteophilic cancer (breast, prostate, lung, kidney, thyroid) proved by pathological
             material, with a high probability of bone metastases

          -  With an indication to a bone examination: systematic search for metastasis for the
             staging or due to clinical or laboratory suspicion of bone metastasis

          -  Registered in a social security health scheme

          -  Written informed consent obtained

        Exclusion Criteria:

          -  Classical contra-indications for PET CT (suspected pregnancy) or MRI (pacemaker,
             ferromagnetic material); for patients with a possibility of pregnancy (women of
             childbearing age without contraception and second part of the menstrual cycle, or the
             slightest suspicion), verification of the absence of pregnancy will be made by the
             beta HCG dosage before injection of radioactive tracer

          -  Uncontrollable claustrophobia with treatment anxiolytic

          -  Antitumor treatment started between the two imaging tests

          -  Imaging or treatment needed in emergency, if both tests are not performable in time
             required for the care

          -  Inaugural neurological complication

          -  Patient unable to undergo biomedical research (under guardianship or deprived of
             liberty)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yacine MERROUCHE</last_name>
    <role>Study Director</role>
    <affiliation>Institut Jean-Godinot</affiliation>
  </overall_official>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>August 18, 2016</last_update_submitted>
  <last_update_submitted_qc>August 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

